Literature DB >> 25370043

p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas.

Valentina Pinna1, Valentina Lanari1, Paola Daniele1, Federica Consoli1, Emanuele Agolini1, Katia Margiotti2, Irene Bottillo3, Isabella Torrente4, Alessandro Bruselles5, Caterina Fusilli1, Anna Ficcadenti6, Sara Bargiacchi7, Eva Trevisson8, Monica Forzan8, Sandra Giustini9, Chiara Leoni10, Giuseppe Zampino10, Maria Cristina Digilio11, Bruno Dallapiccola11, Maurizio Clementi8, Marco Tartaglia5, Alessandro De Luca1.   

Abstract

Analysis of 786 NF1 mutation-positive subjects with clinical diagnosis of neurofibromatosis type 1 (NF1) allowed to identify the heterozygous c.5425C>T missense variant (p.Arg1809Cys) in six (0.7%) unrelated probands (three familial and three sporadic cases), all exhibiting a mild form of disease. Detailed clinical characterization of these subjects and other eight affected relatives showed that all individuals had multiple cafè-au-lait spots, frequently associated with skinfold freckling, but absence of discrete cutaneous or plexiform neurofibromas, Lisch nodules, typical NF1 osseous lesions or symptomatic optic gliomas. Facial features in half of the individuals were suggestive of Noonan syndrome. Our finding and revision of the literature consistently indicate that the c.5425C>T change is associated with a distinctive, mild form of NF1, providing new data with direct impact on genetic counseling and patient management.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25370043      PMCID: PMC4795103          DOI: 10.1038/ejhg.2014.243

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  18 in total

1.  NF1 gene analysis based on DHPLC.

Authors:  Alessandro De Luca; Anna Buccino; Debora Gianni; Massimo Mangino; Sandra Giustini; Antonio Richetta; Luigina Divona; Stefano Calvieri; Rita Mingarelli; Bruno Dallapiccola
Journal:  Hum Mutat       Date:  2003-02       Impact factor: 4.878

Review 2.  Pleckstrin homology (PH) like domains - versatile modules in protein-protein interaction platforms.

Authors:  Klaus Scheffzek; Stefan Welti
Journal:  FEBS Lett       Date:  2012-06-19       Impact factor: 4.124

3.  Lethal presentation of neurofibromatosis and Noonan syndrome.

Authors:  Carlos E Prada; Yuri A Zarate; Sean Hagenbuch; Anne Lovell; Elizabeth K Schorry; Robert J Hopkin
Journal:  Am J Med Genet A       Date:  2011-05-12       Impact factor: 2.802

4.  Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.

Authors:  Sara Ekvall; Kerstin Sjörs; Anders Jonzon; Mauno Vihinen; Göran Annerén; Marie-Louise Bondeson
Journal:  Am J Med Genet A       Date:  2013-12-19       Impact factor: 2.802

Review 5.  Neurofibromatosis: clinical heterogeneity.

Authors:  V M Riccardi
Journal:  Curr Probl Cancer       Date:  1982-08       Impact factor: 3.187

6.  Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype.

Authors:  Hilde Brems; Magdalena Chmara; Mourad Sahbatou; Ellen Denayer; Koji Taniguchi; Reiko Kato; Riet Somers; Ludwine Messiaen; Sofie De Schepper; Jean-Pierre Fryns; Jan Cools; Peter Marynen; Gilles Thomas; Akihiko Yoshimura; Eric Legius
Journal:  Nat Genet       Date:  2007-08-19       Impact factor: 38.330

7.  A severe form of Noonan syndrome and autosomal dominant café-au-lait spots - evidence for different genetic origins.

Authors:  Anna-Maja Nyström; Sara Ekvall; Bo Strömberg; Gerd Holmström; Ann-Charlotte Thuresson; Göran Annerén; Marie-Louise Bondeson
Journal:  Acta Paediatr       Date:  2008-12-18       Impact factor: 2.299

8.  Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients.

Authors:  E Ars; H Kruyer; M Morell; E Pros; E Serra; A Ravella; X Estivill; C Lázaro
Journal:  J Med Genet       Date:  2003-06       Impact factor: 6.318

9.  Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.

Authors:  A De Luca; I Bottillo; M C Dasdia; A Morella; V Lanari; L Bernardini; L Divona; S Giustini; L Sinibaldi; A Novelli; I Torrente; A Schirinzi; B Dallapiccola
Journal:  J Med Genet       Date:  2007-12       Impact factor: 6.318

Review 10.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321

View more
  48 in total

1.  Genetic basis of neurofibromatosis type 1 and related conditions, including mosaicism.

Authors:  Eric Legius; Hilde Brems
Journal:  Childs Nerv Syst       Date:  2020-06-29       Impact factor: 1.475

2.  NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.

Authors:  Joseph A Toonen; Corina Anastasaki; Laura J Smithson; Scott M Gianino; Kairong Li; Robert A Kesterson; David H Gutmann
Journal:  Hum Mol Genet       Date:  2016-02-16       Impact factor: 6.150

3.  Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types.

Authors:  Eungu Kang; Yoon-Myung Kim; Go Hun Seo; Arum Oh; Hee Mang Yoon; Young-Shin Ra; Eun Key Kim; Heyry Kim; Sun-Hee Heo; Gu-Hwan Kim; Mark J Osborn; Jakub Tolar; Han-Wook Yoo; Beom Hee Lee
Journal:  J Hum Genet       Date:  2019-11-28       Impact factor: 3.172

4.  Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.

Authors:  Corina Anastasaki; Albert S Woo; Ludwine M Messiaen; David H Gutmann
Journal:  Hum Mol Genet       Date:  2015-03-18       Impact factor: 6.150

Review 5.  Emerging therapeutic targets for neurofibromatosis type 1.

Authors:  James A Walker; Meena Upadhyaya
Journal:  Expert Opin Ther Targets       Date:  2018-05-07       Impact factor: 6.902

Review 6.  Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.

Authors:  Morgan E Freret; David H Gutmann
Journal:  J Neurosci Res       Date:  2018-04-28       Impact factor: 4.164

Review 7.  Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

Authors:  Robert Listernick; Rosalie E Ferner; Grant T Liu; David H Gutmann
Journal:  Ann Neurol       Date:  2007-03       Impact factor: 10.422

Review 8.  Contextual signaling in cancer.

Authors:  Laura J Smithson; Corina Anastasaki; Ran Chen; Joseph A Toonen; Sidney B Williams; David H Gutmann
Journal:  Semin Cell Dev Biol       Date:  2016-06-03       Impact factor: 7.727

9.  Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1.

Authors:  Heng Xiao; Lamei Yuan; Hongbo Xu; Zhijian Yang; Feizhou Huang; Zhi Song; Yan Yang; Cheng Zeng; Hao Deng
Journal:  J Mol Neurosci       Date:  2018-07-25       Impact factor: 3.444

10.  Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Douglas R Stewart; Bruce R Korf; Katherine L Nathanson; David A Stevenson; Kaleb Yohay
Journal:  Genet Med       Date:  2018-04-26       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.